Dr Richard Antrobus
| Address: | Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) |
| Tel: | 01865 857419 |
| Email: | |
| Website: | Human Influenza Vaccine Programme |
Principal areas of research Immunology, Influenza vaccine trials. |
|
Research
Since joining the Jenner Institute in October 2010 I have been working on two novel immunization programmes using viral vectored vaccines: Working alongside Sarah Gilbert and Adrian Hill I have been conducting a phase I study of a 'universal vaccine' for influenza. Progress so far indicates that this approach induces a potent T cell response, and I am currently assessing whether this response is equally potent in the elderly.
I have also been working with Ellie Barnes and Paul Klenerman at the Peter Medawar Building for Pathology Research on a hepatitis C vaccine.
Key Publications
Antrobus RD, Hewitt J, Helbert MR. Optimising pre-analytical performance of interferon-gamma release assays for TB exposure. Br J Biomed Sci. 2011;68(2):98-9.
Antrobus RD, Khan N, Hislop AD, Montamat-Sicotte D, Garner LI, Rickinson AB, Moss PA, Willcox BE. Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules. J Infect Dis. 2005 Jun 1;191(11):1842-53.
